U.S. Food and Staples Retail Stock News

BioNTech (NasdaqGS:BNTX) shares have recently drawn investor attention after a period marked by mixed returns, including a gain of about 5% over the past 3 months but a decline of roughly 15% over the past year. See our latest analysis for BioNTech. At the current share price of US$90.00, BioNTech’s recent trading has been fairly muted, with the 30 day share price return down 2.44% and the 90 day share price return up 5.04%, while the 5 year total shareholder return is down 59.43%. This...

Recently, Atlassian was named a Leader in Gartner’s inaugural Magic Quadrant for Developer Productivity Insight Platforms, reflecting strong execution and vision among 12 vendors and coinciding with Q3 FY2026 revenue growth of 32% year over year and cloud revenue growth of 29%. The combination of this third-party validation and the Service Collection surpassing US$1.00 billion in annual recurring revenue underscores Atlassian’s push to become a broader workflow and AI-assisted productivity...

Abbott Laboratories (NYSE:ABT) is rolling out its Instinct continuous glucose monitoring sensor across Europe as part of MiniMed insulin pump systems. The integration brings Abbott's CGM technology directly into new automated insulin delivery platforms for diabetes patients. At the same time, Abbott is increasing its presence in emerging markets through biosimilar and branded generic medicine launches and regulatory approvals. For investors watching Abbott Laboratories, these moves connect...

Nokia Oyj (NYSE:NOK) has drawn investor attention after its shares closed at $13.98, with recent returns mixed across different time frames and longer term performance showing very large total return figures. See our latest analysis for Nokia Oyj. Against this backdrop, Nokia Oyj’s recent 1-day and 7-day share price returns of 1.23% and 3.63% come after a 30-day share price decline of 15.07%. Its year to date share price return of 114.75% and very large multi year total shareholder returns...

Celanese (NYSE:CE) has entered a collaboration with Siegwerk to supply bio-based ethyl acetate for more sustainable printing ink solutions. The partnership focuses on offering a drop-in solvent alternative that aims to reduce reliance on fossil-based materials in packaging and printing applications. For investors tracking Celanese, the Siegwerk collaboration highlights how the company is positioning its specialty chemicals portfolio around lower-impact materials. Celanese already operates...

Commercial Metals (CMC) just turned in a busy Q3 2026, with revenue of about US$2.5b and basic EPS of US$1.56, backed by trailing twelve month revenue of roughly US$8.9b and EPS of US$5.35 that frame the latest quarterly run rate. Over the past year, the company has seen revenue move from about US$7.8b on a trailing basis to roughly US$8.9b, while quarterly EPS ranged from US$0.74 in Q3 2025 to US$1.60 in Q1 2026 before landing at US$1.56 this quarter. This gives investors a clearer view of...

Earlier in June 2026, Peabody’s Australian subsidiaries entered into new A$700,000,000 surety bond facilities with Liberty Mutual and Swiss Re, secured against most of their assets and supported by amendments to the group’s revolving credit facility to permit this additional indebtedness and related liens. The move to replace 100% cash‑collateralised reclamation bonds with these facilities could free up liquidity for Peabody’s Australian operations while introducing new covenant and security...

Inflation at 4.1%, shifting expectations for Fed rate moves and volatile energy prices linked to events in Iran are reshaping how investors look at US value stocks. When markets rethink what cash flows are worth under changing interest rate assumptions, some companies can stand out on traditional measures like P/E, P/B and price to cash flow. This article uses a US Value Stocks screener, built around those valuation metrics and balance sheet strength, to spotlight 3 stocks that appear...

Wondering if Morgan Stanley is still worth considering at today's price, or if most of the easy gains are already behind it? This article explains what the current share price could imply about value. The stock recently closed at US$221.04, with returns of 9.6% over the past month, 21.5% year to date, and 62.0% over the last 12 months, while the past week saw a 1.0% decline. Recent coverage of Morgan Stanley has focused on its position within diversified financials and how investors are...

TD SYNNEX (SNX) has just posted Q2 2026 results with revenue of US$19.6 billion and basic EPS of US$4.20, alongside trailing twelve month revenue of US$69.8 billion and EPS of US$14.03 that reflect the impact of the last four quarters. Over the past year, the company has seen revenue move from US$14.9 billion in Q2 2025 to US$19.6 billion in Q2 2026, while quarterly EPS went from US$2.22 to US$4.20, with trailing twelve month EPS stepping up from US$8.61 to US$14.03 over the same period. For...

Asana (NYSE:ASAN) reported that its Asana Gov platform has achieved FedRAMP Moderate Authorization. This certification allows Asana Gov to be used by U.S. federal, state, and local government agencies, contractors, and educational institutions with defined security and compliance needs. The authorization marks an expansion of Asana's addressable market within regulated public sector environments. Asana is best known for its work management and collaboration software, used by teams to...

Sticky inflation, a higher for longer interest rate outlook from the Fed, and energy costs linked to Middle East tensions are reshaping how investors think about banks and insurance stocks. With headline inflation at 4.1% and core inflation at 3.4%, and no clear sign of quick rate relief, the cost of money and risk pricing are front and center again. This article looks at three large, financially healthy Financials stocks from our screener that appear well aligned with this backdrop, and...

Investors may be wondering whether Seagate Technology Holdings still offers value after a strong run, or if the stock is already priced for perfection. At a last close of US$1,025.36, the stock has fallen about 4.2% over the past week, after very large returns over the past year and multi year period, including a 21.2% gain over the last month and a 256.6% return year to date. Recent coverage has focused on Seagate Technology Holdings as a key player in data storage and related technologies,...

Sphere Entertainment (SPHR) drew fresh attention after unveiling plans for a new Sphere Experience featuring The Rocky Horror Picture Show at Sphere, alongside recent analyst commentary and an update on its quarterly profitability. See our latest analysis for Sphere Entertainment. The recent Rocky Horror Sphere Experience announcement and upbeat analyst commentary have arrived alongside strong share price momentum, with a 30-day share price return of 20.28% and a year-to-date share price...

Constellation Energy (NasdaqGS:CEG) has applied for 20-year license renewals for its Ginna and Nine Mile Point Unit 1 nuclear plants in New York. The proposed extensions would allow the reactors to operate until 2049, subject to regulatory approval. The plants are backed by New York's Zero Emissions Credit program, which supports carbon free generation. Constellation Energy is a major US producer of carbon free electricity, and its New York reactors are part of a broader focus on nuclear...

Marqeta (MQ) has become a focus for investors after a recent earnings report in which both revenue and EBITDA came in ahead of analyst forecasts, yet the stock dropped sharply afterward. See our latest analysis for Marqeta. The recent post earnings drop fits into a wider picture where Marqeta’s 1 day share price return of 0.50% and 30 day share price return of 2.86% contrast with a year to date share price decline of 14.87% and a 1 year total shareholder return decline of 32.36%. This...

Erie Indemnity (ERIE) remains in focus for investors after recent trading left the stock with a gain of about 3% over the past month but a decline of roughly 31% over the past year. See our latest analysis for Erie Indemnity. The recent 3.1% 30 day share price return for Erie Indemnity contrasts with a year to date share price decline of 17.2% and a 1 year total shareholder return decline of 31.2%, suggesting momentum has faded even though the 5 year total shareholder return of 30% is still...

Hormel Foods (HRL) is back in focus after recent trading strength. The stock is up over the past month and past 3 months, prompting investors to reassess how its fundamentals line up today. See our latest analysis for Hormel Foods. The recent 24.6% 1 month share price return and 12.8% 3 month share price return suggest momentum is building for Hormel Foods, even though the 1 year total shareholder return is still down 9.7%. If Hormel Foods has you thinking about what else might be setting up...

If you are wondering whether NBT Bancorp is still reasonably priced after its recent run, the current valuation picture offers a few clear clues and some gray areas worth unpacking. The stock last closed at US$49.26, with returns of 5.5% over 7 days, 5.8% over 30 days, 18.4% year to date, 22.2% over 1 year, 67.7% over 3 years, and 60.2% over 5 years, which naturally raises questions about what is already reflected in the price. Recent news around NBT Bancorp has focused on its position...

Alkami Technology (ALKT) is back in focus after highlighting its work with Landmark Credit Union, where its digital banking platform supported gains in business banking profiles, business deposits, and non-interest income. See our latest analysis for Alkami Technology. Despite the recent Landmark Credit Union case study putting Alkami Technology’s digital banking capabilities in the spotlight, the stock has had a mixed run, with a 7 day share price return of 7.9% but the year to date share...

If you are trying to figure out whether Halliburton stock still offers value after a strong run, the current setup makes the valuation story especially important. The stock last closed at US$34.67, with a 71.9% return over the past year and 17.1% year to date, while also pulling back 15.6% over the past month and 0.7% over the past week. These moves may influence how you think about both upside potential and risk. Recent coverage around Halliburton has focused on its position as a major...

AdaptHealth (AHCO) shares moved after a Truist Securities analyst reiterated a positive rating following recent meetings with management, a reminder that investor sentiment often reacts quickly to updated views on a company’s outlook. See our latest analysis for AdaptHealth. At a share price of US$10.02, AdaptHealth has seen a 7 day share price return of 3.83%, but its 90 day share price return is down 10.54% and the 5 year total shareholder return is down 63.24%. This indicates that recent...

Recently, Vistra Corp. has drawn increased attention as analysts issued favorable coverage citing its position in a restructuring U.S. power market and its role in the Helix Digital Infrastructure platform. These developments underscore how Vistra’s existing generation assets and data center-focused partnerships could reshape its earnings profile as electricity demand evolves. With these analyst endorsements and Vistra’s Helix data center partnership in mind, we’ll now examine how this...

Illinois Medicaid award shifts focus for Humana stock Humana (HUM) is back in the spotlight after Illinois selected the insurer to participate statewide in HealthChoice Illinois, a Medicaid managed care program that could reshape how investors view its government business mix. See our latest analysis for Humana. Humana’s share price has climbed strongly in recent months, with a 24.63% 1 month share price return, a 122.37% 3 month share price return and a 59.58% 1 year total shareholder...